基于胶原蛋白的血管闭合装置与缝线闭合血管装置相比，意大利多中心血管内主动脉瘤修复经验

IF 16.4 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Accounts of Chemical Research Pub Date : 2024-09-17 DOI:10.1177/15266028241275804

Marco Panagrosso, Eduardo Cavallo, Umberto Marcello Bracale, Antonio Peluso, Olga Silvestri, Francesco Intrieri, Vincenzo Molinari, Antonio Esposito, Santi Trimarchi, Alberto Maria Settembrini, Chiara Lomazzi, Gaetano La Barbera, Luciano Carbonari, Andrea Angelini, Irene Morelli, Eleonora Centonza, Raffaella Berchiolli, Nicola Troisi, Valentina Scarati, Valerio Artini, Salvatore De Vivo, Pietro Volpe, Mafalda Massara, Eugenio Martelli

{"title":"基于胶原蛋白的血管闭合装置与缝线闭合血管装置相比，意大利多中心血管内主动脉瘤修复经验","authors":"Marco Panagrosso, Eduardo Cavallo, Umberto Marcello Bracale, Antonio Peluso, Olga Silvestri, Francesco Intrieri, Vincenzo Molinari, Antonio Esposito, Santi Trimarchi, Alberto Maria Settembrini, Chiara Lomazzi, Gaetano La Barbera, Luciano Carbonari, Andrea Angelini, Irene Morelli, Eleonora Centonza, Raffaella Berchiolli, Nicola Troisi, Valentina Scarati, Valerio Artini, Salvatore De Vivo, Pietro Volpe, Mafalda Massara, Eugenio Martelli","doi":"10.1177/15266028241275804","DOIUrl":null,"url":null,"abstract":"Purpose:The Manta Vascular Closure Device is a novel collagen-based vascular closure device that has been designed specifically for closure of large-bore percutaneous arterial accesses. The aim of this retrospective study is to evaluate the immediate and 30-day outcome of Manta at the completion of endovascular aneurysm repair (EVAR) or thoracic endovascular aortic repair (TEVAR). The hypothesis is that Manta is not inferior in obtaining hemostasis compared with the Perclose ProGlide Suture-Mediated Closure System device.Materials and Methods:We recruited all the percutaneous accesses for (T)EVAR performed from January 2021 to April 2023 by all the Italian Divisions of Vascular Surgery using Manta at the time of data collection (May 2023). The primary outcome is to evaluate the incidence of complications at the puncture site after Manta implantation and at 1 month, and compare this with ProGlide. We applied the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) criteria for observational studies.Results:Overall, 524 consecutive femoral accesses for (T)EVAR procedures were collected: 355 in the Manta cohort and 169 in the ProGlide cohort, respectively. The size of the sheath was 17.2±2.7 Fr for Manta, 15.7±2.3 Fr for ProGlide (p<0.001). No statistically significant differences between the groups regarding age, sex, body mass index, ultrasound-guided access, femoral calcifications, intraoperative, and 30-day complications. Successful arterial closure at groin puncture sites for (T)EVAR using Manta is 90.5% and 93.1% using ProGlide. Freedom for any reintervention for any complication is 95.5% for Manta and 96% for ProGlide.Conclusion:The 2 vascular closure devices have proved to be similar in terms of complications, without any statistically significant difference, although the median size of the sheaths for (T)EVAR was statistically significantly larger when Manta has been used, compared with ProGlide.Clinical ImpactManta® is effective in the hemostasis of the access sites following the completion of (T)EVAR in this multicenter, retrospective, case-control study on 524 percutaneous femoral accesses. Compared to the more popular Proglide®, the average size of the introducers in the Manta® group was significantly larger than in the Proglide® group.","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Collagen-Based Vascular Closure Device Multicenter Italian Experience in Endovascular Aortic Aneurysm Repair Compared With Suture-Mediated Closure Vascular Device\",\"authors\":\"Marco Panagrosso, Eduardo Cavallo, Umberto Marcello Bracale, Antonio Peluso, Olga Silvestri, Francesco Intrieri, Vincenzo Molinari, Antonio Esposito, Santi Trimarchi, Alberto Maria Settembrini, Chiara Lomazzi, Gaetano La Barbera, Luciano Carbonari, Andrea Angelini, Irene Morelli, Eleonora Centonza, Raffaella Berchiolli, Nicola Troisi, Valentina Scarati, Valerio Artini, Salvatore De Vivo, Pietro Volpe, Mafalda Massara, Eugenio Martelli\",\"doi\":\"10.1177/15266028241275804\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose:The Manta Vascular Closure Device is a novel collagen-based vascular closure device that has been designed specifically for closure of large-bore percutaneous arterial accesses. The aim of this retrospective study is to evaluate the immediate and 30-day outcome of Manta at the completion of endovascular aneurysm repair (EVAR) or thoracic endovascular aortic repair (TEVAR). The hypothesis is that Manta is not inferior in obtaining hemostasis compared with the Perclose ProGlide Suture-Mediated Closure System device.Materials and Methods:We recruited all the percutaneous accesses for (T)EVAR performed from January 2021 to April 2023 by all the Italian Divisions of Vascular Surgery using Manta at the time of data collection (May 2023). The primary outcome is to evaluate the incidence of complications at the puncture site after Manta implantation and at 1 month, and compare this with ProGlide. We applied the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) criteria for observational studies.Results:Overall, 524 consecutive femoral accesses for (T)EVAR procedures were collected: 355 in the Manta cohort and 169 in the ProGlide cohort, respectively. The size of the sheath was 17.2±2.7 Fr for Manta, 15.7±2.3 Fr for ProGlide (p<0.001). No statistically significant differences between the groups regarding age, sex, body mass index, ultrasound-guided access, femoral calcifications, intraoperative, and 30-day complications. Successful arterial closure at groin puncture sites for (T)EVAR using Manta is 90.5% and 93.1% using ProGlide. Freedom for any reintervention for any complication is 95.5% for Manta and 96% for ProGlide.Conclusion:The 2 vascular closure devices have proved to be similar in terms of complications, without any statistically significant difference, although the median size of the sheaths for (T)EVAR was statistically significantly larger when Manta has been used, compared with ProGlide.Clinical ImpactManta® is effective in the hemostasis of the access sites following the completion of (T)EVAR in this multicenter, retrospective, case-control study on 524 percutaneous femoral accesses. Compared to the more popular Proglide®, the average size of the introducers in the Manta® group was significantly larger than in the Proglide® group.\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2024-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/15266028241275804\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028241275804","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

摘要

目的：Manta 血管闭合装置是一种基于胶原蛋白的新型血管闭合装置，专为闭合大口径经皮动脉通路而设计。这项回顾性研究的目的是评估 Manta 在完成血管内动脉瘤修补术（EVAR）或胸腔内主动脉修补术（TEVAR）后的即时和 30 天疗效。材料与方法：我们收集了 2021 年 1 月至 2023 年 4 月期间意大利所有血管外科分部使用 Manta 进行的所有经皮入路 (T)EVAR 手术（数据收集时为 2023 年 5 月）。主要结果是评估 Manta 植入术后一个月穿刺部位并发症的发生率，并与 ProGlide 进行比较。我们对观察性研究采用了 STROBE（加强流行病学观察性研究报告）标准：Manta队列中有355例，ProGlide队列中有169例。Manta 的鞘管尺寸为 17.2±2.7Fr，ProGlide 为 15.7±2.3Fr（p<0.001）。两组在年龄、性别、体重指数、超声引导入路、股骨钙化、术中和 30 天并发症方面的差异无统计学意义。使用 Manta 进行 (T)EVAR 时，腹股沟穿刺点动脉闭合成功率为 90.5%，使用 ProGlide 时为 93.1%。结论：事实证明，这两种血管闭合器在并发症方面相似，没有任何统计学上的显著差异，但与 ProGlide 相比，使用 Manta 时，(T)EVAR 的鞘中位尺寸在统计学上明显更大。在这项针对 524 个经皮股骨通路的多中心、回顾性、病例对照研究中，Manta® 在完成 (T)EVAR 后对通路部位的止血效果显著。与更受欢迎的 Proglide® 相比，Manta® 组的导引器平均尺寸明显大于 Proglide® 组。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Collagen-Based Vascular Closure Device Multicenter Italian Experience in Endovascular Aortic Aneurysm Repair Compared With Suture-Mediated Closure Vascular Device

Purpose:The Manta Vascular Closure Device is a novel collagen-based vascular closure device that has been designed specifically for closure of large-bore percutaneous arterial accesses. The aim of this retrospective study is to evaluate the immediate and 30-day outcome of Manta at the completion of endovascular aneurysm repair (EVAR) or thoracic endovascular aortic repair (TEVAR). The hypothesis is that Manta is not inferior in obtaining hemostasis compared with the Perclose ProGlide Suture-Mediated Closure System device.Materials and Methods:We recruited all the percutaneous accesses for (T)EVAR performed from January 2021 to April 2023 by all the Italian Divisions of Vascular Surgery using Manta at the time of data collection (May 2023). The primary outcome is to evaluate the incidence of complications at the puncture site after Manta implantation and at 1 month, and compare this with ProGlide. We applied the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) criteria for observational studies.Results:Overall, 524 consecutive femoral accesses for (T)EVAR procedures were collected: 355 in the Manta cohort and 169 in the ProGlide cohort, respectively. The size of the sheath was 17.2±2.7 Fr for Manta, 15.7±2.3 Fr for ProGlide (p<0.001). No statistically significant differences between the groups regarding age, sex, body mass index, ultrasound-guided access, femoral calcifications, intraoperative, and 30-day complications. Successful arterial closure at groin puncture sites for (T)EVAR using Manta is 90.5% and 93.1% using ProGlide. Freedom for any reintervention for any complication is 95.5% for Manta and 96% for ProGlide.Conclusion:The 2 vascular closure devices have proved to be similar in terms of complications, without any statistically significant difference, although the median size of the sheaths for (T)EVAR was statistically significantly larger when Manta has been used, compared with ProGlide.Clinical ImpactManta® is effective in the hemostasis of the access sites following the completion of (T)EVAR in this multicenter, retrospective, case-control study on 524 percutaneous femoral accesses. Compared to the more popular Proglide®, the average size of the introducers in the Manta® group was significantly larger than in the Proglide® group.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Accounts of Chemical Research 化学-化学综合

CiteScore

31.40

自引率

1.10%

发文量

312

审稿时长

2 months

期刊介绍： Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.